Clearmind Medicine Inc (CMND)

$0.13 0.00 (-2.34%)
Market Cap 1.24M
Revenue (ttm) 0.00
Net Income (ttm) -5.25M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 7,371,100
Avg Vol 15,486,502
Day's Range N/A - N/A
Shares Out 9.60M
Stochastic %K 28%
Beta 1.18
Analysts Strong Buy
Price Target N/A

Company Profile

Clearmind Medicine Inc., a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression. The company develops MEAI compound for the treatment of alcohol use disorder, obesity, and metabolic disorders, as well...

Industry: Biotechnology
Sector: Healthcare
Phone: 973 536 1016
Address:
1220 West 6th Avenue, Suite 101, Vancouver, Canada
JohnTrack
JohnTrack Dec. 6 at 12:35 AM
$CMND watching if shorts cover...
0 · Reply
Kmoy1776
Kmoy1776 Dec. 5 at 11:52 PM
$CMND Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has been granted a 180-calendar day compliance period, or until June 2, 2026, to regain compliance with the minimum bid price requirement. FDA will answer BEFORE Jan 2, 2026….not worried
1 · Reply
JohnTrack
JohnTrack Dec. 5 at 10:17 PM
$CMND expected, but not good news... https://www.rapidticker.com/news/cmnd-sec-filing-73a616
2 · Reply
sirspanky
sirspanky Dec. 5 at 10:13 PM
$CMND we going to the moon. $INHD I know you are rolling down that hill with a little bump or 2 there to take profit. Take a look at the long term wedge pattern on this one which it broke today.. This is in for a massive correction.
1 · Reply
Felixii
Felixii Dec. 5 at 10:06 PM
$CMND monday 🚀
0 · Reply
SaySomethingNice
SaySomethingNice Dec. 5 at 9:43 PM
$CMND accumulation mode, ✅️
0 · Reply
shuffle13
shuffle13 Dec. 5 at 7:44 PM
$CMND peoples thoughts on the offering...completed? https://www.sec.gov/Archives/edgar/data/1892500/000121390025117534/ea0268220-424b5_clearmind.htm
0 · Reply
Bat_shtt_crazy
Bat_shtt_crazy Dec. 5 at 7:41 PM
$CMND Someone’s getting spanked soon. That 120,000,000 plus naked paper sell the other day is going to be a ouchie
0 · Reply
sirspanky
sirspanky Dec. 5 at 7:34 PM
$CMND Bounced on the Pixel haha. Next week we see what this 4 hour chart going to do if not AH. Stay frosty.
0 · Reply
Goldwave9
Goldwave9 Dec. 5 at 7:01 PM
$BIYA $CDT $CMND $LFWD MYSZ Enjoy the quiet before the storm. But don't put a time clock on it.
1 · Reply
Latest News on CMND
Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification

Dec 5, 2025, 5:00 PM EST - 2 hours ago

Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification

Clearmind Medicine Advances CMND-100 to Dosing Phase at Hadassah Medical Center in Ongoing Phase I/IIa Clinical Trial for Alcohol Use Disorder

Dec 2, 2025, 7:57 AM EST - 3 days ago

Clearmind Medicine Advances CMND-100 to Dosing Phase at Hadassah Medical Center in Ongoing Phase I/IIa Clinical Trial for Alcohol Use Disorder

Clearmind Medicine Charges Forward in Alcoholism Treatment: Positive Cohort Data, Full DSMB Approval, and New Elite Site Joins the Clinical Trial

Dec 1, 2025, 8:56 AM EST - 4 days ago

Clearmind Medicine Charges Forward in Alcoholism Treatment: Positive Cohort Data, Full DSMB Approval, and New Elite Site Joins the Clinical Trial

Clearmind Medicine Kicks-Off Patient Enrollment at Tel Aviv Sourasky Medical Center, Adding Another Site Activated in its in Phase I/IIa Alcohol Use Disorder Trial

Nov 25, 2025, 7:17 AM EST - 10 days ago

Clearmind Medicine Kicks-Off Patient Enrollment at Tel Aviv Sourasky Medical Center, Adding Another Site Activated in its in Phase I/IIa Alcohol Use Disorder Trial

Clearmind Medicine's Data and Safety Monitoring Board Unanimously Approves Continuation of Phase I/IIa Clinical Trial for CMND-100 Following Positive Interim Safety Review

Nov 24, 2025, 8:51 AM EST - 11 days ago

Clearmind Medicine's Data and Safety Monitoring Board Unanimously Approves Continuation of Phase I/IIa Clinical Trial for CMND-100 Following Positive Interim Safety Review

Clearmind Medicine Accelerate FDA-Approved Alcohol Use Disorder Clinical Trial by Activating Fifth Elite Global Medical Site

Nov 20, 2025, 6:01 AM EST - 15 days ago

Clearmind Medicine Accelerate FDA-Approved Alcohol Use Disorder Clinical Trial by Activating Fifth Elite Global Medical Site

Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression

Nov 19, 2025, 8:30 AM EST - 16 days ago

Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression

SPRC

Clearmind Medicine Announces Positive Top-Line Results from First Cohort of its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder

Nov 18, 2025, 8:56 AM EST - 17 days ago

Clearmind Medicine Announces Positive Top-Line Results from First Cohort of its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder

Clearmind Medicine Files Israeli Patent for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression

Nov 17, 2025, 7:55 AM EST - 18 days ago

Clearmind Medicine Files Israeli Patent for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression

Clearmind Medicine Receives Final Approval to Expand its FDA Regulated Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center

Nov 13, 2025, 8:54 AM EST - 22 days ago

Clearmind Medicine Receives Final Approval to Expand its FDA Regulated Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center

Clearmind Medicine Announces Notice of Patent Publication for Depression Treatment

Nov 12, 2025, 6:25 AM EST - 23 days ago

Clearmind Medicine Announces Notice of Patent Publication for Depression Treatment

Clearmind Medicine Successfully Completed First Cohort Treatment in its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder

Nov 10, 2025, 8:07 AM EST - 25 days ago

Clearmind Medicine Successfully Completed First Cohort Treatment in its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder

Clearmind Medicine Receives Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency

Nov 6, 2025, 4:02 PM EST - 4 weeks ago

Clearmind Medicine Receives Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency

Clearmind Expands Global IP Protection for MEAI in Depression Treatment with New South Korea Patent Filing

Nov 5, 2025, 6:55 AM EST - 4 weeks ago

Clearmind Expands Global IP Protection for MEAI in Depression Treatment with New South Korea Patent Filing

Clearmind Medicine Completes First Cohort Treatment in its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder

Oct 30, 2025, 7:55 AM EDT - 5 weeks ago

Clearmind Medicine Completes First Cohort Treatment in its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder

Clearmind Medicine CEO Dr. Adi Zuloff-Shani to Speak at Women in Psychedelic Leadership Webinar

Oct 28, 2025, 8:08 AM EDT - 5 weeks ago

Clearmind Medicine CEO Dr. Adi Zuloff-Shani to Speak at Women in Psychedelic Leadership Webinar

Clearmind Medicine Appoints Mary-Elizabeth Gifford as Chief of Global Impact to Advance US Partnerships and Governmental Engagement

Oct 27, 2025, 9:22 AM EDT - 5 weeks ago

Clearmind Medicine Appoints Mary-Elizabeth Gifford as Chief of Global Impact to Advance US Partnerships and Governmental Engagement

Clearmind Medicine Enrolls Last Patient for the First Cohort of its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder

Oct 21, 2025, 7:25 AM EDT - 6 weeks ago

Clearmind Medicine Enrolls Last Patient for the First Cohort of its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder

Clearmind Medicine Announces Publication of U.S. Patent Application Targeting Binge Behavior Disorders

Oct 20, 2025, 7:41 AM EDT - 6 weeks ago

Clearmind Medicine Announces Publication of U.S. Patent Application Targeting Binge Behavior Disorders

Clearmind Medicine's Convenes Inaugural Scientific Advisory Board Meeting to Advance Psychedelic-Derived Therapies

Sep 25, 2025, 7:40 AM EDT - 2 months ago

Clearmind Medicine's Convenes Inaugural Scientific Advisory Board Meeting to Advance Psychedelic-Derived Therapies

Clearmind Medicine Secures $10 million Securities Purchase Agreement to Explore Strategic Opportunities

Sep 19, 2025, 8:20 AM EDT - 2 months ago

Clearmind Medicine Secures $10 million Securities Purchase Agreement to Explore Strategic Opportunities

Clearmind Medicine Announces Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar

Aug 7, 2025, 7:32 AM EDT - 4 months ago

Clearmind Medicine Announces Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar

Clearmind Medicine Receives IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center

Aug 5, 2025, 8:15 AM EDT - 4 months ago

Clearmind Medicine Receives IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center

Clearmind Medicine Files International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease

Jul 30, 2025, 8:18 AM EDT - 4 months ago

Clearmind Medicine Files International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease

Clearmind Medicine Completes Initiation of Leading Israeli Clinical Site for Phase I/IIa Trial of CMND-100 in Alcohol Use Disorder

Jul 23, 2025, 8:55 AM EDT - 4 months ago

Clearmind Medicine Completes Initiation of Leading Israeli Clinical Site for Phase I/IIa Trial of CMND-100 in Alcohol Use Disorder

Clearmind Expands its Clinical Trial for Alcohol Use: New Site Activated and Additional Participant Enrolled

Jul 15, 2025, 8:05 AM EDT - 5 months ago

Clearmind Expands its Clinical Trial for Alcohol Use: New Site Activated and Additional Participant Enrolled

Clearmind Medicine Announces IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Tel Aviv Sourasky Medical Center

Jul 3, 2025, 8:47 AM EDT - 5 months ago

Clearmind Medicine Announces IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Tel Aviv Sourasky Medical Center

Clearmind Medicine Announces First Participant Ever Dosed with its CMND-100 Treatment in Groundbreaking Clinical Trial for Alcohol Use Disorder

Jun 30, 2025, 9:16 AM EDT - 5 months ago

Clearmind Medicine Announces First Participant Ever Dosed with its CMND-100 Treatment in Groundbreaking Clinical Trial for Alcohol Use Disorder

Clearmind Medicine Expands Global Clinical Trial Targeting Multibillion-Dollar Alcohol Use Disorder Market

Jun 27, 2025, 9:00 AM EDT - 5 months ago

Clearmind Medicine Expands Global Clinical Trial Targeting Multibillion-Dollar Alcohol Use Disorder Market

Clearmind Medicine Enrolls First Patient in its Clinical Trial for Alcoholism Treatment

Jun 25, 2025, 7:48 AM EDT - 5 months ago

Clearmind Medicine Enrolls First Patient in its Clinical Trial for Alcoholism Treatment

Clearmind Medicine Joins Forces with Leading US Political Firm to Promote Psychedelic Therapeutics

Jun 24, 2025, 8:06 AM EDT - 5 months ago

Clearmind Medicine Joins Forces with Leading US Political Firm to Promote Psychedelic Therapeutics

Clearmind Medicine Adds Leading Israeli Clinical Site to Its Ongoing Clinical Trial for Alcohol Use Disorder

Jun 23, 2025, 7:55 AM EDT - 5 months ago

Clearmind Medicine Adds Leading Israeli Clinical Site to Its Ongoing Clinical Trial for Alcohol Use Disorder

Clearmind Medicine Engages Leading Government and Political Affairs Firm to Advance Psychedelic Therapeutics

Jun 12, 2025, 9:25 AM EDT - 6 months ago

Clearmind Medicine Engages Leading Government and Political Affairs Firm to Advance Psychedelic Therapeutics

Clearmind Medicine Announces Enrollment of First Patient in Phase I/IIa Clinical Trial for Alcohol Use Disorder Treatment

Jun 5, 2025, 7:32 AM EDT - 6 months ago

Clearmind Medicine Announces Enrollment of First Patient in Phase I/IIa Clinical Trial for Alcohol Use Disorder Treatment

Clearmind Medicine to Host Live Webinar “Gazing Through the Crystal Ball” Featuring Leading Psychedelic Experts

May 20, 2025, 9:00 AM EDT - 7 months ago

Clearmind Medicine to Host Live Webinar “Gazing Through the Crystal Ball” Featuring Leading Psychedelic Experts

SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders

Apr 25, 2025, 7:59 AM EDT - 8 months ago

SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders

SPRC

Clearmind Medicine Files International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders

Apr 25, 2025, 7:55 AM EDT - 8 months ago

Clearmind Medicine Files International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders

Clearmind Medicine Completes the Initiation of its Alcohol Use Disorder Phase I/IIa Clinical Trial at all Current Clinical Sites

Apr 23, 2025, 8:25 AM EDT - 8 months ago

Clearmind Medicine Completes the Initiation of its Alcohol Use Disorder Phase I/IIa Clinical Trial at all Current Clinical Sites

Clearmind Medicine Receives Notice of Allowance for United States Patent Covering Binge Behavior

Apr 17, 2025, 7:38 AM EDT - 8 months ago

Clearmind Medicine Receives Notice of Allowance for United States Patent Covering Binge Behavior

Clearmind Medicine Launches First U.S. Clinical Site for its FDA-Approved Clinical Trial to Combat Alcoholism

Apr 16, 2025, 8:40 AM EDT - 8 months ago

Clearmind Medicine Launches First U.S. Clinical Site for its FDA-Approved Clinical Trial to Combat Alcoholism

Clearmind Medicine Announces First U.S. Clinical Site Initiation for CMND-100 Clinical Trial in Patients with Alcohol Use Disorder

Apr 10, 2025, 8:25 AM EDT - 8 months ago

Clearmind Medicine Announces First U.S. Clinical Site Initiation for CMND-100 Clinical Trial in Patients with Alcohol Use Disorder

Clearmind Medicine Announces the Publication of International Patent Application for Next-Gen Psychedelic Compounds to Treat Mental Health Disorders

Apr 8, 2025, 6:55 AM EDT - 8 months ago

Clearmind Medicine Announces the Publication of International Patent Application for Next-Gen Psychedelic Compounds to Treat Mental Health Disorders

Clearmind Launches its EDC System to Support its Phase I/II Clinical Trial of its MEAI-Based Treatment

Apr 1, 2025, 8:15 AM EDT - 8 months ago

Clearmind Launches its EDC System to Support its Phase I/II Clinical Trial of its MEAI-Based Treatment

Clearmind Medicine's FDA-Approved Clinical Trial for CMND-100 Moves Forward as Drug Arrives in the U.S., Advancing Toward Key Milestones

Mar 21, 2025, 9:28 AM EDT - 9 months ago

Clearmind Medicine's FDA-Approved Clinical Trial for CMND-100 Moves Forward as Drug Arrives in the U.S., Advancing Toward Key Milestones

Clearmind to Evaluate Intranasal Delivery of Its Psychedelic Drug Combination

Mar 19, 2025, 7:35 AM EDT - 9 months ago

Clearmind to Evaluate Intranasal Delivery of Its Psychedelic Drug Combination

Clearmind Medicine Announces Initiation of First in Human Clinical Trial with CMND-100 in Alcohol Use Disorder Patients

Mar 18, 2025, 7:32 AM EDT - 9 months ago

Clearmind Medicine Announces Initiation of First in Human Clinical Trial with CMND-100 in Alcohol Use Disorder Patients

Clearmind Medicine Announces Publication of Patent for Binge Behavior Psychedelic Combination Treatment in Mexico

Feb 4, 2025, 8:35 AM EST - 10 months ago

Clearmind Medicine Announces Publication of Patent for Binge Behavior Psychedelic Combination Treatment in Mexico

Clearmind Medicine Announces Shareholders Meeting Results

Jan 7, 2025, 9:28 AM EST - 11 months ago

Clearmind Medicine Announces Shareholders Meeting Results

Clearmind Medicine Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment

Jan 6, 2025, 8:15 AM EST - 11 months ago

Clearmind Medicine Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment

Clearmind Medicine Granted Patent for Binge Behavior Treatment by the Macau International Intellectual Property Office

Jan 2, 2025, 7:45 AM EST - 1 year ago

Clearmind Medicine Granted Patent for Binge Behavior Treatment by the Macau International Intellectual Property Office

JohnTrack
JohnTrack Dec. 6 at 12:35 AM
$CMND watching if shorts cover...
0 · Reply
Kmoy1776
Kmoy1776 Dec. 5 at 11:52 PM
$CMND Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has been granted a 180-calendar day compliance period, or until June 2, 2026, to regain compliance with the minimum bid price requirement. FDA will answer BEFORE Jan 2, 2026….not worried
1 · Reply
JohnTrack
JohnTrack Dec. 5 at 10:17 PM
$CMND expected, but not good news... https://www.rapidticker.com/news/cmnd-sec-filing-73a616
2 · Reply
sirspanky
sirspanky Dec. 5 at 10:13 PM
$CMND we going to the moon. $INHD I know you are rolling down that hill with a little bump or 2 there to take profit. Take a look at the long term wedge pattern on this one which it broke today.. This is in for a massive correction.
1 · Reply
Felixii
Felixii Dec. 5 at 10:06 PM
$CMND monday 🚀
0 · Reply
SaySomethingNice
SaySomethingNice Dec. 5 at 9:43 PM
$CMND accumulation mode, ✅️
0 · Reply
shuffle13
shuffle13 Dec. 5 at 7:44 PM
$CMND peoples thoughts on the offering...completed? https://www.sec.gov/Archives/edgar/data/1892500/000121390025117534/ea0268220-424b5_clearmind.htm
0 · Reply
Bat_shtt_crazy
Bat_shtt_crazy Dec. 5 at 7:41 PM
$CMND Someone’s getting spanked soon. That 120,000,000 plus naked paper sell the other day is going to be a ouchie
0 · Reply
sirspanky
sirspanky Dec. 5 at 7:34 PM
$CMND Bounced on the Pixel haha. Next week we see what this 4 hour chart going to do if not AH. Stay frosty.
0 · Reply
Goldwave9
Goldwave9 Dec. 5 at 7:01 PM
$BIYA $CDT $CMND $LFWD MYSZ Enjoy the quiet before the storm. But don't put a time clock on it.
1 · Reply
sirspanky
sirspanky Dec. 5 at 6:47 PM
$CMND if you know what your're doing sure is
1 · Reply
Trabetrash
Trabetrash Dec. 5 at 6:43 PM
$CMND totally predictable??? Fuck you!!
0 · Reply
sirspanky
sirspanky Dec. 5 at 6:25 PM
$CMND flirting with that moving average line like last time before the leg up. Isnt this a cool company with what they do? I'm glad to be in this one from the story perspective not just the movements it will give.
0 · Reply
sirspanky
sirspanky Dec. 5 at 5:46 PM
$CMND healthy movement in the short term to pull back and rise higher. Thanks for the market sells I've been gobbling up. Totally predictable
1 · Reply
Trabetrash
Trabetrash Dec. 5 at 5:29 PM
$CMND finished
0 · Reply
sirspanky
sirspanky Dec. 5 at 5:21 PM
$CMND mind science meets markets 🧠⚡ Company focus: leveraging psychedelic-assisted therapies + neurotech to tackle hard problems (TRD/PTSD/substance use). Think: measurable clinical endpoints, safer protocols, real-world access instead of hype. Why I’m watching: • Micro-cap + tight float = high elasticity to news (trial progress, site activations, collabs). • Sector tailwind: growing acceptance of psychedelic medicine as payers/providers hunt for outcomes. • Setup near lows → asymmetry if any validation drops. Squeeze angle: Thin tape + improving narrative can move fast. Compare the “culture tailwind” we saw in $TLRY $CGC $SNDL — different space, same viral energy potential if catalysts hit. Price now: $0.126. Eyes on trial/milestone headlines. Not advice—do your DD. 🚀🧪
0 · Reply
Kmoy1776
Kmoy1776 Dec. 5 at 5:14 PM
$CMND slap the ask and hold. pretty simple
0 · Reply
sirspanky
sirspanky Dec. 5 at 5:11 PM
$CMND
0 · Reply
sirspanky
sirspanky Dec. 5 at 4:52 PM
$INHD Got stopped out luckily on the inital drop. Charts look kinda like the game is over here. IF you look over at $CMND however on the 4 hour its breaking out on the 4 hour falling wedge. MACD looks sexy sooo this could be a runner and we are at the basement.
0 · Reply
sirspanky
sirspanky Dec. 5 at 4:45 PM
$CMND Thanks!
0 · Reply
sirspanky
sirspanky Dec. 5 at 4:30 PM
$CMND can someone sell this in a large market order for me?
3 · Reply
jnicoles1
jnicoles1 Dec. 5 at 4:02 PM
$CMND https://www.tipranks.com/news/the-fly/psychedelic-clearmind-reports-cmnd-100-dosing-at-hadassah-medical-center-thefly
0 · Reply